All posts by imreal

Larry Wilson’s newly released “Holy Ghost Powered! The Prayer of Faith and Deliverance by Praying and Confessing the Word of God” use scripture to create powerful prayer


News Image

“Holy Ghost Powered! The Prayer of Faith and Deliverance by Praying and Confessing the Word of God”: a potent arrangement of thought-provoking and spiritually inspired by the Word of God. “Holy Ghost Powered! The Prayer of Faith and Deliverance by Praying and Confessing the Word of God” is the testimony of published author Larry Wilson: The Servant of The Most High, who through personal tests and trials has learned to pray God’s word and overcame the darkness of this world in his personal life. Larry Wilson is a native of Louisiana with a passion for spreading the Word of God.

Wilson shares, “The prayers in this book are designed to demolish all the wiles of the devil in our personal lives and in the lives of the members of our household. We need powerful prayers to abolish the works of the evil one in our lives. God’s Word released through our mouth will cause his power to be manifested in our lives. He watches over his word to perform it. The Word of God is like the fire that burns, it is the hammer that breaks the rocks in pieces Jeremiah 23:29.

“For the weapons which we use are not earthly weapons but of the might of God by which we conquer rebellious strong holds, casting down imaginations, and every false thing that exalts itself against the knowledge of God, and capturing every thought to the obedience of Christ. 2 Corinthians 10:4-5.

“It is important that we, the believers, be strong in the LORD and in the power of his might. We walk and war in His strength, and this requires humility, and total dependence on God. We must depend on His Word and His Spirit to overcome the darkness of this world.

“Ephesians 6:12-13 For your conflict is not only with flesh and blood, but also with the angels, and with powers, and with the rulers of this world of darkness, the evil spirits under the heavens. Therefore, put on the whole armor of God that you may be able to meet the evil one, and being prepared you shall prevail.

“This was key to David’s victories. David was a king who knew how to depend upon God. David won his battles and overcame all his enemies through the power and might of God. This was done by prayer, David knew how to reach God through prayer.”

Published by Christian Faith Publishing, Larry Wilson, The Servant of The Most High’s new book will excite the spirit and inspire the soul as readers take time to truly immerse themselves in God’s Word.

Wilson’s passion for prayer and spreading God’s Word is apparent within the pages of this informative and encouraging work.

Consumers can purchase “Holy Ghost Powered! The Prayer of Faith and Deliverance by Praying and Confessing the Word of God” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Holy Ghost Powered! The Prayer of Faith and Deliverance by Praying and Confessing the Word of God,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Pride Foods Signs Canadian Crossfit Legend Patrick Vellner to the Team


Paul Vellner Crossfit Competitor

“The level at which these men and women perform is extremely high. And so follows their need to fuel and replenish. Pride will be a valuable & tasty tool they can use to help push their performance,” said Pride Foods, CEO Shaun Vazquez.

Coming off the heels of their Pride Crispies launch, Pride Food takes another giant leap forward by signing their very first athlete, Canadian CrossFit legend and Chiropractor Patrick Vellner.

Elite athletes and fitness enthusiasts want to fuel their bodies with foods that can enhance their performance. Whether it’s intense training sessions or competing at the highest level at the CrossFit Games, Pride Foods is there to help optimize endurance and performance.

“I have been very excited about the possibility of breaking into the functional fitness category for some time now. The level at which these men and women perform is extremely high. And so follows their need to fuel and replenish. Pride will be a valuable & tasty tool they can use to help push their performance. And share with their families. We are pumped to have Pat on the team ! As a hardworking husband, father, businessman and someone with a great sense of humor, he is a natural fit. The team and I are looking forward to attending our first CrossFit Games in Madison this year and watching Pat fight for a top placing, once again!”, said Pride Foods, CEO Shaun Vazquez.

Pride Foods provides consumers with better-for-you ingredients that utilize healthy carbohydrates — an essential macro-nutrient that athletes across the globe leverage to meet the demands of their strenuous energy requirements to perform at the highest level.

Patrick Vellner is no stranger to fueling his body for optimal performance as he attempts to make history by winning the 2022 CrossFit Games. After securing a #1 ranking in the world in 2020 and taking home a win in the 2021 Atlas Games, Patrick is looking to continue his dominance in the sport moving into the 2020 CrossFit Games.

“Pride Foods is rapidly growing and it’s great to see the expand their footprint in functional fitness with an athlete of Paul’s caliber. The physical demands of Crossfit are extreme and therefore they require excellent nutrition to keep them fueled. The synergies between Pride and Vellner will be strong,” said Spry Tribe, CEO Daniel Pierce.

Pride Foods has made its mark on the industry by introducing a delicious and flavorful hot cereal with their Rice’ N Grinds. In July 2022, they launched a healthier alternative to a childhood favorite — the Pride Crispies Bar. The Pride Crispies Bar is a take- anywhere snack option that has been adult-tested and kid-approved with its premium ingredients and lower sugar content compared to similar products.

Whether you’re looking to start your day with a healthy breakfast or carry around a healthy snack to help get you through the most demanding day, Pride Foods is there to fuel your mind and body.

About Pride Foods: Pride Foods is a veteran-owned and operated business out of Oklahoma City, OK, that produces healthy foods and snacks by utilizing healthy carbohydrates and ingredients that focus on performance and fuel. They take PRIDE in ensuring that not only all products and ingredients are of the highest quality possible, but that every product in their line is manufactured right here in the USA.

About Spry Tribe: With a collective 20+ years of active nutrition nutrition experience, the team at Spry Tribe has gained attention as a global digital marketing and innovation leader specializing in food and nutrition marketing. They have commercialized over 2,000 products globally, including running the associated go-to-market and lifecycle marketing campaigns across Amazon, major detail, and direct to consumer channels.

Share article on social media or email:

Pet Parents® Ranks No. 1860 on the 2022 Inc. 5000 Annual List


Pet Parents®

Pet Parents®

Our exciting growth showcases our dedication to pet parents and furbabies everywhere. We are honored to be ranked on the Inc. 5000 list for the third consecutive year. This achievement confirms that our efforts align with pet parenting needs.

Inc. revealed that Pet Parents is No. 1860 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Blake Anderson, founder and CEO of Pet Parents®, says, “One of our core values at Pet Parents is to be the Top Dog. We take ownership of our work to constantly improve and strive to add value in everything we do. Our exciting growth showcases our dedication to pet parents and furbabies everywhere. We are honored to be ranked on the Inc. 5000 list for the third consecutive year. This achievement confirms that our efforts align with pet parenting needs.”

The companies on the 2022 Inc. 5000 have not only been successful, but have also demonstrated resilience amid supply chain woes, labor shortages, and the ongoing impact of Covid-19. Among the top 500, the average median three-year revenue growth rate soared to 2,144 percent. Together, those companies added more than 68,394 jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are featured in the September issue of Inc. magazine, which will be available on August 23.

“The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated,” says Scott Omelianuk, editor-in-chief of Inc. “Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today.”

Pet Parents® began its journey in the beginning of 2016 & continues to grow in size every year. Recognized by Inc. 5000 for being one of the fastest-growing companies in America in 2020, 2021, and 2022 Pet Parents® creates products to help pet parents raise their pets from birth to senior years, keeping their homes clean and pet families happy and healthy. Pet Parents® brand & product lines are at the crossing point of two macro pet industry trends: the humanization of pets with a focus on healthcare.

Learn more about Pet Parents® at https://petparentsbrand.com/.

Follow Pet Parents® on social: Facebook, Instagram, LinkedIn, Pinterest, YouTube, and TikTok.

For more information, contact Sydney Klein. Email: Press@PetParentsBrand.com.

More about Inc. and the Inc. 5000

Methodology

Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2018 to 2021. To qualify, companies must have been founded and generating revenue by March 31, 2018. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2021. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2018 is $100,000; the minimum for 2021 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places. The top 500 companies on the Inc. 5000 are featured in Inc. magazine’s September issue. The entire Inc. 5000 can be found at http://www.inc.com/inc5000.

About Inc.

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference & Gala is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference & Gala, visit http://conference.inc.com/.

Share article on social media or email:



Shady Grove Fertility Colorado physician Nanette Santoro, M.D., named to 5280 magazine’s 2022 Top Doctors list


SGF Colorado physician Dr. Santoro earns an honored distinction as a Top Doctor for Infertility in the Denver area from 5280 magazine.

“Helping people expand their families is such a rewarding experience. I am thankful my patients entrust me with their care, and I am honored to be recognized by my physician peers as a Top Doctor for Infertility in Denver.”

Shady Grove Fertility (SGF) is proud to announce that Nanette Santoro, M.D., who sees patients at SGF Colorado’s Denver location, has been named to 5280 magazine’s 2022 Top Doctors for Infertility list.

5280 conducts an annual peer-to-peer survey to name the Top Doctors of the Denver area. 343 doctors—in 100 specialties—were nominated by their peers this year. For the past 28 years, 5280 has surveyed doctors and asked them, specialty by specialty, which metro-area physicians they would trust to treat themselves and their families.

“Helping people expand their families is such a rewarding experience,” shares Dr. Santoro. “I am thankful my patients entrust me with their care, and I am honored to be recognized by my physician peers as a Top Doctor for Infertility in Denver.”

Get to know Dr. Santoro and SGF Colorado

Dr. Santoro completed her medical training in the 6-year B.S.-M.D. program at Rensselaer Polytechnic Institute and Albany Medical College, followed by a residency at Beth Israel Medical Center in New York City and a fellowship in Reproductive Endocrinology at Massachusetts General Hospital, where she remained on faculty for 3 years prior to joining the faculty at New Jersey Medical School in 1988.

An accomplished researcher, Dr. Santoro’s current exploration involves treatment of menopausal symptoms in women, understanding the mechanisms by which obesity causes relative infertility in women, participating in clinical trials in reproductive medicine, and research training of OB/GYNs and reproductive endocrinologists.

Dr. Santoro sees SGF Colorado patients at the Denver location, while also maintaining her position at Colorado University treating women for complex menopause management. Additionally, Dr. Santoro provides training to the University of Colorado Reproductive Endocrinology and Infertility fellowship program.

SGF Colorado’s Denver location offers comprehensive fertility services, including:

  • fertility and ovarian reserve testing and diagnosis,
  • semen analysis,
  • hysterosalpingogram (HSG),
  • low-tech fertility treatment options such as intrauterine insemination (IUI),
  • in vitro fertilization (IVF),
  • donor egg, sperm, and embryo,
  • genetic screening and testing,
  • gestational carrier,
  • egg freezing,
  • fertility preservation for patients with cancer, and
  • LGBTQ+ family building.


“Providing affordable, accessible fertility care makes a difference in the lives of those who will experience infertility,” adds Dr. Santoro. “SGF’s innovative financial plans make treatment more affordable and truly reiterate our ‘patients come first’ mentality.”

Given the staggering fact that one in eight couples of reproductive age are in need of fertility care, it’s reassuring that SGF Colorado offers an expansive insurance network as well as unique financial programs for self-pay patients. Their hallmark program, the Shared Risk 100% Refund Guarantee Program, offers patients the reassurance they will either take home a baby or receive a full refund. SGF also provides income-based and military discounts.

New patients may schedule an appointment with Dr. Santoro at SGF Colorado’s Denver location by calling the SGF New Patient Center at 720-778-3810 or submitting this brief online form.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 47 locations, including new locations in Texas, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies


“AGC Biologics has an outstanding track record of success in the manufacture of clinical and commercial advanced therapies and an ever-expanding global network to meet the needs of our customers.” – Tim Kelly, CEO, RoosterBio

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services.

The partnership creates an end-to-end solution for the development and production of hMSC and exosome therapeutics leveraging RoosterBio’s well-established cell and media products and process development services, coupled with AGC Biologics’ global cell and gene therapy manufacturing capabilities.

RoosterBio will utilize its extensive portfolio of cell and media products to develop robust, scalable processes for hMSC and exosome therapies. These capabilities include genetic engineering of cells and exosomes to express therapeutic targets, upstream processing in both 2D flask and 3D bioreactor systems, downstream purification to achieve desired purity and potency, and comprehensive analytical characterization of the resulting formulated cell or exosome therapy.

AGC Biologics will utilize its global network to provide full Process Development, cGMP Manufacturing, Quality Control and Regulatory services for pre-clinical and phase I/II clinical trials, with the ability to scale to Phase III and commercial production. The CDMO also offers a range of development and manufacturing scales that can be tailored to the specific needs of drug developers in different regions worldwide. The AGC Biologics scientific teams have over two decades of experience in advanced therapy production and manufacturing and have brought three commercial products to market. The global CDMO’s network of sites offers the latest cell therapy technologies and processes, including allogenic and autologous systems and techniques.

“AGC Biologics is happy to be partnering with RoosterBio. They have a reliable method for producing engineered cells and exosomes that can help developers create life-saving therapies,” said Patricio Massera, Chief Executive Officer of AGC Biologics. “When you combine their work and expertise with AGC Biologics’ scientific knowledge and global manufacturing services, it creates a comprehensive offering that can help these developers save time and money and get their treatments in the hands of patients in need.”

“AGC Biologics has an outstanding track record of success in the manufacture of clinical and commercial advanced therapies and an ever-expanding global network to meet the needs of our customers,” said Tim Kelly, Chief Executive Officer of RoosterBio. “Biopharmaceutical companies striving to develop engineered cell and exosome therapies require proven, flexible technologies paired with reliable and scalable manufacturing solutions. This collaboration was conceived to deliver that end-to-end solution for our customers, and I am thrilled to partner with AGC Biologics to translate our hMSC and exosome technologies into advanced therapy products that have the potential to bring curative treatments to patients in need.”

More details on this partnership and the joint offering from RoosterBio and AGC Biologics will be released in the coming months.

AGC Biologics’ global cell therapy services and viral vector capabilities utilize proprietary platforms developed to address the evolving advanced therapies market. To learn more about the company and its complete list of CDMO services visit http://www.agcbio.com.

About RoosterBio

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable regenerative cures. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year. RoosterBio is driven by client’s success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

http://www.roosterbio.com

LinkedIn: RoosterBio

About AGC Biologics

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. To learn more, visit http://www.agcbio.com.

LinkedIn: AGC Biologics

Share article on social media or email:

SPK and Associates Partners with Greenlight Guru to provide Medical Device Solutions that accelerate the delivery of life-changing devices.


SPK & Associates and Greenlight Guru announced today that the companies have entered into a strategic partnership that will improve the quality of life by helping medical device companies and manufacturers get to market faster with less risk.

SPK & Associates is a leading woman-owned Engineering & IT Services Company that serves product development teams. For 20 years, SPK has helped customers harness technology to optimize engineering and attain their business goals. They understand the systems, processes, data and applications critical to successful product development, and dedicate themselves to helping clients release products faster and better. Their core expertise covers four functional areas: Product Lifecycle Management (MCAD, PLM, PDM); Software Lifecycle Management (ALM, DevOps); Cloud for Engineering (Infrastructure, Security); Data Engineering and Analytics.

Greenlight Guru has pioneered the only MedTech Lifecycle Excellence (MLE) platform purpose-built to give medical technology companies an end-to-end software solution to bring life-changing products to people. The platform integrates cross-functional teams, processes, and data throughout the product lifecycle, giving visibility and traceability beyond compliance requirements to proactively overcome execution gaps and reach market success.

“Greenlight Guru is pleased to partner with a leading services firm to assist product development teams in accelerating their products to market. Our current and future customers can benefit from their trusted expertise in order to optimize resources and bring innovative solutions to patients – faster and better,” said David DeRam, CEO of Greenlight Guru. “Manufacturers either bringing new innovations to market or maintaining existing portfolios will benefit from the deep subject-matter expertise offered by the SPK team.”

“We are delighted to have partnered with such an inspiring company like Greenlight Guru. They truly are trying to help companies make life changing devices and deliver that value more quickly than was possible in the past. This aligns extremely well to our goal of accelerating product delivery for our clients,” said Chris McHale, CEO for SPK and Associates. “The days of old-fashioned, slow, expensive, and hard-to-manage systems for purely compliance are over. We’re excited about being part of the technology and automation revolution for the medical device industry.”

Both SPK & Associates and Greenlight Guru are looking to lower the risk for medical device manufacturing companies by providing the platform and leveraging the knowledge of years of work in the field.

Both companies are planning a joint webinar to be conducted on August 25, 2022 at 1pm ET / 10am PT. People interested in how the two companies will be helping fill the gaps for medical device companies should register for the webinar here.

This partnership helps medical device companies looking to accelerating product development with SPK’s services, alongside leveraging Greenlight Guru to bring quality, regulatory, clinical, and product development activities across the entire device lifecycle into a single, purpose-built platform.

Share article on social media or email:

Cures Act Ready MeldRx™ Ecosystem for EHRs Launched by Darena Solutions


Many EHRs are still not sure if they want to buy or build a solution to meet the fast-approaching (g)(10) deadlines for the FHIR APIs. MeldRx Lite will allow EHRs to evaluate our complete solution while avoiding decertification and other penalties.- WAYNE SINGER, VP of REGULATORY SERVICES

MeldRx™ Ecosystem offers a comprehensive solution that includes what the Cures Act requires now and what EHRs and providers would need to benefit from true healthcare data interoperability. The Ecosystem is built around the nation’s first Certified FHIR API solution, BlueButtonPRO, which completes the loop of creating, sharing, and receiving data. The data gathered from various sources can be organized to construct a longitudinal health record to provide better real-time insights.

With the MeldRx Lite, the EHRs can test drive the MeldRx Ecosystem and enable EHRs to “Certify and Provide” the FHIR API to their providers to avoid Information Blocking penalties to meet the Cures Act requirements for $5k in a phased manner.

“Many EHRs are still not sure if they want to buy or build a solution to meet the fast-approaching (g)(10) deadlines for the FHIR APIs. MeldRx Lite will allow EHRs to evaluate our complete solution while avoiding decertification and other penalties.” Says Wayne Singer, VP of Regulatory Services.

The MeldRx Lite version will help EHRs and providers to not only meet but exceed Cures Act requirements with the following features:

  • ONC 2015 Edition Certified FHIR API for (g)(10)
  • Developer Portal required to approve third-party apps that desire to connect through an EHR’s API
  • C-CDA Importer to create USCDI data from the C-CDA
  • Document Importer to meet all the EHI requirements required from Oct. 6, 2022, onward
  • SMART® On FHIR Apps for providers and patients
  • Provider Portal to allow providers to send patient invites and share the data with the patients to comply with the Cures Act, Information blocking, and MIPS

“With MeldRx Lite, our goal is to allow EHRs to meet the (g)(10) certification for only $5K with no long-term commitment. EHRs can cancel anytime on or before Dec. 31, 2023, or transition to the full MeldRx solution by Oct 1, 2023. We are also giving EHRs an opportunity to exit any existing contracts they may have signed with other vendors by offering a credit up to the total cost of the integration.” Says Satish Subramani, EVP of Strategic Accounts.

Learn more about the features of MeldRx and MeldRx Lite

ABOUT MELDRX

MeldRx™ is a technology platform designed by Darena Solutions to solve the unique challenges of Healthcare Data Management by leveraging open standards, established data security best practices, and collaboration between Patients, Providers, Researchers, and Health IT Developers.

ABOUT DARENA SOLUTIONS

Darena Solutions delivers an Ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to EHRs, providers, and payers. By creating channels for data sharing between providers, payers, and patients, Darena enables healthcare organizations to achieve compliance and derive insights for prospective decision-making resulting in better patient outcomes. You can connect with us on LinkedIn and Twitter.

Share article on social media or email:



Applied Radiology and Bracco Diagnostics Inc. Launch ‘Leaders on the Horizon’ Residents Program


News Image

“In publication for over 50 years, Applied Radiology has enjoyed the opportunity to work with the smartest minds in medical imaging, and this includes opportunities to work with young residents”, said Kieran Anderson, vice president and group publisher, Anderson Publishing, Ltd.

With support from Bracco Diagnostics Inc., Anderson Publishing, Ltd., publishers of Applied Radiology are pleased to announce the launch of “Leaders on the Horizon,” an exciting new program for radiology residents. Open to qualified U.S.-based radiology residents, Leaders on the Horizon aims to support their continued education in radiology with an initiative designed to refine their scholarly research and writing skills, coupled with the opportunity to attend the Radiological Society of North America (RSNA) annual meeting and network with fellow residents, key opinion leaders, and industry representatives.

For 2022, participating residents are invited to develop and submit a clinical research paper on a topic related to the use of magnetic resonance imaging (MRI). All papers must be submitted by Oct. 3, 2022. The papers will be reviewed by a designated committee of key opinion leaders in radiology, and the five best papers will be published in a special supplement to Applied Radiology in early 2023.

The top five residents will receive a monetary scholarship award to support their continued education in the field of medical imaging. The top two residents will have an opportunity to join us at RSNA 2022, where they will be honored at a special reception on Sunday, November 27, 2022.

“In publication for over 50 years, Applied Radiology has enjoyed the opportunity to work with the smartest minds in medical imaging, and this includes opportunities to work with young residents. We are extremely proud to be a part of this industry and the development of a program like this that will support and cultivate future thought leaders in radiology,” said Kieran Anderson, vice president and group publisher, Anderson Publishing, Ltd.

“One of Bracco Diagnostics’ core missions is to advance knowledge, leadership, and education to help radiology succeed and grow both today and into the future. Leaders on the Horizon fills a need for resident education and support, and we are thrilled to fund this timely initiative,” said Noelle Heber, senior director, contrast media marketing, Bracco Diagnostics.

U.S.-based residency program directors and coordinators are urged to share this exciting opportunity with their residents. More details can be found at http://www.appliedradiology.com/leaders.

About Applied Radiology

Applied Radiology is a physician-authored, clinical-review journal that has been published for over 50 years and reaches radiologists and related imaging professionals in print and digital formats. Its comprehensive content includes practical review articles, radiological cases, technology and industry updates, editorials, and related columns. Applied Radiology is published by Anderson Publishing, Ltd., a multimedia company dedicated to the development of high-quality, clinically relevant content designed to meet the needs of today’s medical imaging professionals.

Learn more at http://www.appliedradiology.com

About Bracco Diagnostics Inc.

Bracco Diagnostics Inc., located in Monroe Township, NJ, is a U.S. subsidiary of Bracco Imaging S.p.A., part of the Bracco Group, a world-leading diagnostic imaging provider. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures, and markets diagnostic imaging agents and solutions. It offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray imaging (including Computed Tomography (C)T, interventional radiology, and cardiac catheterization), magnetic resonance imaging (MRI), contrast-enhanced ultrasound (CEUS), and nuclear medicine through radioactive tracers and novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Our continually evolving portfolio is completed by a range of medical devices, advanced administration systems, and dose-management software. Visit: http://www.braccoimaging.com.

Contact

Anderson Publishing, Ltd.

Kieran Anderson

Vice President

kieran@appliedradiology.com

D: +1 908-337-3366

Bracco Diagnostics Inc. Media Relations (USA)

Kimberly Gerweck

Senior Manager, Marketing Communications

BDIMediaContact@diag.bracco.com

D: +1 609-524-2777

Share article on social media or email:

EmpowerU Launches Self-Care and Mental Health Support for K–12 Teachers and Administrators


News Image

“We have been overwhelmed by the response from educators and administrators telling us about their renewed passion for teaching after taking this EmpowerU course,” said Katie Dorn, CEO and co-founder of EmpowerU.

EmpowerU, a leading provider of evidence-based, turnkey student and educator wellbeing programs that build strong foundations in resilience, motivation and confidence, today announced the national rollout of its Educator Self-Care and Mental Health professional development program for K–12 teachers and administrators.

The professional development course, which EmpowerU created with a team of licensed mental health clinicians, features a self-paced and on-demand format. Available via any internet-connected device, the training takes 10-12 clock hours to complete, which educators in the initial phase typically spread over 4-6 weeks.

“I just completed the EmpowerU course and it was amazing,” said Michelle Koch, dean of students at Menahga Public School District 821, in a video. “Understanding our emotions and reactions to emotions are valuable skills and a message we need right now. Every minute of my time with EmpowerU was positive, focused on what I could do and what I could control. It was incredible. I am going to shout from the rooftops what a powerful and purposeful program this is.”

Since the beginning of the pilot, thousands of educators have taken the course, with 80% of participants opting to include coaching by EmpowerU’s trained clinicians. These coaches provide online, asynchronous support that helps educators apply what they learn to their own lives so they can improve their wellbeing first, then pass that learning on to their students. Feedback from those educators has been overwhelmingly positive:

  • 99% of educators who took the course said it was helpful to their wellbeing, motivation, and mental health.
  • 98% of respondents said the support they received daily from their EmpowerU instructor was important to their growth.
  • 97% said they would recommend the course to other teachers and educators.
  • 100% made progress toward their goals, leaving them more engaged and renewed for the upcoming school year.

“We have been overwhelmed by the response from educators and administrators telling us about their renewed passion for teaching after taking this EmpowerU course,” said Katie Dorn, CEO and co-founder of EmpowerU.

“Over the past few years, educators have faced enormous stress, which can lead to burnout and compassion fatigue. We created this training to help them put the oxygen mask on themselves first so they could better support students, so it’s incredibly validating when educators say things like, ‘I feel like I have a better, healthier control over my anxiety and stress. I have tools and skills to use when I feel it coming on too strong. I also have the tools to help my students with this as well.’”

During the initial phase of the program, most schools paid for their educators and administrators to take the course using professional development or staff wellbeing funds, but at just $59 per educator without coaching and $129 per educator with coaching, EmpowerU’s Self-Care and Mental Health Support for K–12 Teachers and Administrators is designed to fit in almost anywhere in the budget.

For more information, visit EmpowerU.education.

About EmpowerU

EmpowerU’s highly personalized, online SEL program helps young people replace anxiety and depression with resilience and confidence, fueling student transformation without a heavy lift for staff or the need for additional hires. The program provides each student with interactive lessons and personalized coaching, pairing technology with brain research in a unique way that supports students and empowers their growth. Multi-year data makes it clear: Nobody understands Multi-Tiered System of Supports (MTSS) and approaches SEL the way EmpowerU does.

Share article on social media or email:

New Study from The Fenway Institute Finds Significant Barriers to Gender-Affirming Primary Care among Transgender People Living in Rural Areas


Rectangular blue Fenway Health logo with white letters

These findings point to a real need for more comprehensive training in gender-affirming health care for all primary care clinicians.

A study published in LGBT Health found a high prevalence of barriers to gender-affirming primary care among transgender and gender diverse (TGD) people living in rural areas across five Northeastern states. Findings from the study also suggest that TGD people in rural areas receive suboptimal levels of preventive sexual health screening. The study contributes important new knowledge to the primary care needs of rural-dwelling TGD people, as nearly all of the existing literature on the primary care needs of TGD people focuses on those who live in urban areas.

“One quarter of participants in this study reported that they had no access at all to gender-affirming primary care and nearly 10 percent reported that they had been refused care by a doctor,” said study senior author Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program. “These findings point to a real need for more comprehensive training in gender-affirming health care for all primary care clinicians.”

The study, titled “Gender-Affirming Primary Care Access Among Rural Transgender and Gender Diverse Adults in Five Northeastern U.S. States,” surveyed 244 TGD adults residing in rural counties of less than 500 people per square mile in Connecticut, Massachusetts, New Hampshire, New York, and Vermont. Participants were asked questions about where they received primary care and if they experienced any barriers to care. Approximately 40 percent of participants identified as nonbinary or gender diverse, 33.5 percent identified as transgender men, and 26.2 identified as transgender women.

Important findings from this study include the following:

  • 65.6 % of study participants reported that there were no gender-affirming clinicians available where they access primary care
  • 25.7 % reported that they were not able to access any gender-affirming primary care at all
  • 8.2 % reported that a doctor had refused to provide gender-affirming care
  • 30.2% reported that they had postponed preventive care for fear of experiencing disrespect or mistreatment based on their gender identity
  • 28.7% reported that they had postponed seeking medical care when they were sick or injured for fear of experiencing disrespect or mistreatment based on their gender identity
  • 17.2% reported having to visit an emergency department or urgent care clinic because they had postponed medical care that could have been provided on a non-urgent basis for fear of experiencing discrimination
  • 47.5 %reported that they experienced difficulty scheduling appointments
  • 51.6% reported that they had to travel at least two hours for gender-affirming primary care
  • Nonbinary study participants and transgender women were more likely to experience barriers to gender-affirming care than transgender men with only 27.9 percent of nonbinary participants and 31.7 of transgender women reporting current access to gender-affirming primary care as compared with 40.5 percent of transgender men.


Additionally, 59 percent of study participants reported a lack of overall clinical skill among clinicians. High percentages of participants reported that they had never been tested for HIV (20.3%) or any sexually-transmitted infections (18%) which suggests suboptimal levels of preventive sexual health screening regardless of access to gender-affirming primary care.

“This study suggests that there are plenty of opportunities to make system-level improvements in primary care for transgender and gender diverse adults living in rural areas,” Keuroghlian added. “Interventions are needed to alleviate the higher burden of adverse health outcomes experienced by transgender people.”

“Gender-Affirming Primary Care Access Among Rural Transgender and Gender Diverse Adults in Five Northeastern U.S. States” is available here.

Share article on social media or email: